Katayama T, Conn P M
Department of Pharmacology, University of Iowa College of Medicine, Iowa City 52242-1109.
Endocrinology. 1994 Jan;134(1):119-25. doi: 10.1210/endo.134.1.8275926.
This study was performed to assess the effects of activin on intracellular mechanisms involved in GnRH action. When rat pituitary cell cultures were pretreated with activin-A (5-80 ng/ml) for 3 days, subsequent FSH and LH release (percentage of total cellular FSH and LH released during 4 h) in response to GnRH (10(-10)-10(-6) M) was not significantly different from that in cells pretreated with medium alone. In contrast, activin pretreatment increased the potency of both A23187 (Ca2+ ionophore) and phorbol 12-myristate 13-acetate [a protein kinase-C (PKC) activator] as secretagogues for FSH and LH release. FSH or LH release in response to another Ca(2+)-mobilizing secretagogue, maitotoxin (an activator of the GnRH receptor-associated Ca2+ channel), was not increased by activin. Although PKC is capable of influencing the actions of Ca2+, which is believed to be the second messenger for GnRH action, neither GnRH- nor maitotoxin-stimulated gonadotropin release was increased by activin even when the influence of activin on PKC was eliminated by the addition of a PKC inhibitor (staurosporine; 100 nM) during the final 30 min of the 3-day pretreatment period. These results indicate that although activin does not influence GnRH action with regard to gonadotropin release, it increases the sensitivity of the system regulating gonadotropin release to increases in cytosolic Ca2+ concentrations and PKC activation. Furthermore, activin appears to exhibit an inhibitory effect(s) at some point(s) in GnRH action in a PKC-independent manner, which could be responsible for opposing the increased sensitivity of the gonadotrope to Ca2+. The differential effects of activin on gonadotropin release in response to Ca(2+)-mobilizing secretagogues (ionophore and maitotoxin) raise the possibility that the activity of the GnRH receptor-associated Ca2+ channel may be suppressed by activin.
本研究旨在评估激活素对促性腺激素释放激素(GnRH)作用所涉及的细胞内机制的影响。当用激活素-A(5 - 80 ng/ml)对大鼠垂体细胞培养物进行预处理3天时,随后对GnRH(10⁻¹⁰ - 10⁻⁶ M)作出反应时,卵泡刺激素(FSH)和促黄体生成素(LH)的释放量(4小时内释放的细胞总FSH和LH的百分比)与仅用培养基预处理的细胞相比无显著差异。相反,激活素预处理增强了钙离子载体A23187和佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(一种蛋白激酶C(PKC)激活剂)作为FSH和LH释放促分泌剂的效力。激活素并未增加对另一种钙离子动员促分泌剂——刺尾鱼毒素(一种GnRH受体相关钙离子通道的激活剂)作出反应时的FSH或LH释放量。尽管PKC能够影响钙离子的作用,而钙离子被认为是GnRH作用的第二信使,但即使在3天预处理期的最后30分钟添加PKC抑制剂(星形孢菌素;100 nM)以消除激活素对PKC的影响,激活素也未增加GnRH或刺尾鱼毒素刺激的促性腺激素释放。这些结果表明,尽管激活素在促性腺激素释放方面不影响GnRH作用,但它增加了调节促性腺激素释放的系统对胞质钙离子浓度升高和PKC激活的敏感性。此外,激活素似乎以一种不依赖PKC的方式在GnRH作用的某些点上表现出抑制作用,这可能是对抗促性腺细胞对钙离子敏感性增加的原因。激活素对钙离子动员促分泌剂(离子载体和刺尾鱼毒素)作出反应时促性腺激素释放的不同影响增加了激活素可能抑制GnRH受体相关钙离子通道活性的可能性。